Screener
Xeris Biopharma Holdings, Inc. XERS Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The source filing: Xeris Biopharma Holdings, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001867096-26-000065
FAQ
- What is Xeris Biopharma Holdings, Inc.'s inventories?
- Xeris Biopharma Holdings, Inc. (XERS) reported inventories of $80.93M in Q2 2026.
- How has Xeris Biopharma Holdings, Inc.'s inventories changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s inventories increased by 20.3% year-over-year, from $67.28M to $80.93M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s inventories?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s inventories has grown at a 52.4% compound annual growth rate (CAGR), from $8.35M to $68.67M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about Xeris Biopharma Holdings, Inc.'s inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude